Chester County News and Community Website
WILMINGTON, DE — Prelude Therapeutics Inc. (Nasdaq: PRLD) received U.S. Food and Drug Administration clearance to begin a Phase 1 trial of PRT13722, moving its experimental KAT6A-targeting breast cancer drug …
Prelude Wins FDA Clearance to Move Breast Cancer Drug to Trial Read More
WASHINGTON, D.C. — The U.S. Department of Energy selected four projects for $73 million in funding to establish domestic mining-technology test sites, seeking to move new extraction and processing systems …
DOE Directs $73 Million to Test New U.S. Mining Technology Read More
WILMINGTON, DE — AstraZeneca’s (NYSE: AZN) ETCAMAH (camizestrant) combination won accelerated U.S. approval for certain advanced breast cancer patients whose tumors develop an ESR1 mutation during first-line therapy, allowing treatment …
FDA Clears AstraZeneca Breast Cancer Regimen on Early Detection Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) received FDA authorization to begin an NDA-enabling Phase 2b study of SkinJect in patients with Gorlin Syndrome, advancing the company’s lead program …
FDA Clears Medicus SkinJect Study for Gorlin Syndrome Read More
EXTON, PA — Uwchlan Township supervisors will resume a public hearing Tuesday on Rockwell Downingtown LLC’s proposed 492-home development along Lionville Station Road, a plan that would create a new …
Uwchlan Weighs 492-Home Plan for School District Property Read More
WEST CHESTER, PA — Birmingham Township supervisors will consider on Sept. 8 whether to open two commercial zoning districts to data centers under conditional-use rules that would impose restrictions on …
Birmingham Weighs Data Center Rules With Power Limits Read More
HARRISBURG, PA — Pennsylvania’s fish and wildlife agencies face unsustainable spending that could exhaust or nearly eliminate their reserves by fiscal 2034, according to an independent review recommending workforce reductions, …
Report Urges Pa. Wildlife Job Cuts as Reserves Dwindle Read More
SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) secured U.S. Food and Drug Administration approval for IMAAVY to treat warm autoimmune hemolytic anemia in patients 12 and older who …
FDA Clears J&J’s IMAAVY as First Drug for Rare Blood Disease Read More WASHINGTON, D.C. — The U.S. Department of Energy has selected seven projects for $500 million in funding to expand domestic critical-mineral processing, battery manufacturing and recycling, targeting supply chain vulnerabilities …
Energy Department Commits $500 Million to U.S. Battery Supply Read More
WASHINGTON, D.C. — The U.S. Department of Agriculture is offering $7.5 million in grants to expand refrigeration and cold-storage capacity across emergency food networks, enabling food banks and other assistance …
USDA Offers $7.5 Million to Expand Food Bank Cold Storage Read More